Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > All negative bashing comments
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(135)
•••
Comment by Walter333on Mar 22, 2022 8:13am
144 Views
Post# 34533708

RE:RE:All negative bashing comments

RE:RE:All negative bashing comments
Mil_Man54 wrote: Sticking with that shorter BS still Rosenberg....if I were shorting this stcok...I'd be a millionaire by now.....and do you actually consider the SP down 99% "normal part of market activity"....please try and justify that brain dead statement.....and that "time will tell" line is getting old....they are again below the delisting threshold on the NASDAQ with no signs of recovery and even if they begin there trial in Q4 as they stated they were "hoping" to...they will have been delisted by then as there is NOTHING that will prop up the SP....so again Rosenberg....F all the way off!.....

DavidRosenberg wrote: Come from shorts - ignore them they make money if SP goes down just normal part of market activity

cheers

Real results are needed to move the needle time will tell if they are able to execute on their vision.




Anthony does have a mid 90% failure rate executing on as you say all of his so called "visions" when it comes to his startups.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities